Patents

US 12371666 B2: Nucleoside modified mRNA and uses thereof

Granted
2025-07-29
Filed
2022-11-08 application 17982753
Type
Utility · 22 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present application discloses compositions and methods for use of nucleoside modified mRNA that encode for at least one liver regenerative factor. The present invention also relates to compositions and methods for use of nucleoside modified mRNA complexed to nanoparticles. The disclosed compositions and methods are useful for treating acute liver diseases, chronic liver diseases, and/or acetaminophen (acetyl-para-aminophenol, APAP) overdose.

Source: PVGPATDIS, file of 2026-04-10 (ipg250729.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
BOSTON MEDICAL CENTER CORPORATION 46 patentsUS company or organizationBoston, MABOSTON MEDICAL CENTER CORPORATION Nonprofit EXACT high confidence: identical full name and state
BOSTON MEDICAL CENTER Federal lobbying client FUZZY medium confidence: same name (legal endings aside) and state
PVGPATDIS, file of 2026-04-10
The Trustees of the University of Pennsylvania 1,699 patentsUS company or organizationPhiladelphia, PAUniversity of Pennsylvania College or university FUZZY medium confidence: same name (governing-board words and legal endings aside) and state
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA Nonprofit FUZZY medium confidence: same name (governing-board words and legal endings aside) and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Valerie Gouon-EvansNewton, MA1PVGPATDIS, file of 2026-04-10
Drew WeissmanPhiladelphia, PA31PVGPATDIS, file of 2026-04-10
Norbert PardiPhiladelphia, PA6PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N5/0679PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K31/198PVGPATDIS, file of 2026-04-10
C07KPeptidesC07K14/47PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2024-11-13Other
License
BOSTON UNIVERSITY MEDICAL CAMPUS signed 2022-11-10NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT BETHESDA, MD69247/113ECORSEXC, file of 2026-09-25
2023-02-08Assignment
Assignment of assignor's interest
GOUON-EVANS, VALERIE signed 2023-01-27BOSTON MEDICAL CENTER CORPORATION BOSTON, MA62630/860ECORSEXC, file of 2026-09-25
2023-01-17Assignment
Assignment of assignor's interest
PARDI, NORBERT signed 2023-01-13THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA PHILADELPHIA, PA62398/570ECORSEXC, file of 2026-09-25
2023-01-17Assignment
Assignment of assignor's interest
WEISSMAN, DREW signed 2023-01-13THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA PHILADELPHIA, PA62398/555ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.